Join IAG’s Bio Partnering Team at ACR Convergence 2022, Philadelphia, for a Cheese&Wine Reception at the Wanamaker Building, Saturday 12th November, 6:00-8:30pm
If you are attending the American College of Rheumatology Convergence (ACR 22) it would be our pleasure to host you at a private reception at the iconic Wanamaker Building in historic Philadelphia, 12th November 2022, 6:00-8:30pm.
The reception will be hosted at IAG’s offices and start with a quick tour of this famous building. Built in 1911, The Wanamaker Building is a landmark that originally housed one of the first department stores in America. In the background you will hear the famous pipe organ play as you immerse yourself in rich Philadelphia history.
Then, Dr. Olga Kubassova and Dr. Francesco Del Galdo will speak about importance of quantitative imaging in clinical trials. We will present on the most recent AI-driven endpoint that has been added to DYNAMIKA platform, DAVIX©. Dr. Kubassova will speak about the most recent developments at IAG, our recent partnerships and future plans.
At IAG, IMAGE ANALYSIS GROUP, we believe that precision medicine is gaining the much needed momentum in both clinical practice and clinical research. We see that the development and successful deployment of #artificial or #augmented intelligence across the entire workflow is the next step in accelerating drug development and ensuring #clinicaltrials’ success.
If you are interested to join us in Philadelphia, please email us at: imaging.experts@ia-grp.com and we’ll add you to the guest list!
We look forward to seeing you there!
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: wp1.ia-grp.com
Reach out: imaging.experts@ia-grp.com
Follow the Company: Linkedin